Dermagnostix creates ground-breaking dermatology diagnostics to promote clinical practice and enhance patient experiences.
Dermagnostix has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in March 2022.
Dermagnostix's investors include European Innovation Council.
Dermagnostix is headquartered in Freiburg, Germany.
Dermagnostix creates ground-breaking dermatology diagnostics to promote clinical practice and enhance patient experiences.
Dermagnostix is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dermagnostix — Funding & Investors." VCBacked, March 23, 2022, https://www.vcbacked.co/company/dermagnostix. Accessed July 20, 2026.
VCBacked. (2022). Dermagnostix — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/dermagnostix
{{cite web |title=Dermagnostix — Funding & Investors |url=https://www.vcbacked.co/company/dermagnostix |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated